Bloomberg Business, October 23, 2020. We, with other, scientists and advocates criticize weak Covid-19 vaccine standards at FDA Advisory Panel Meeting.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
FDA Panel To Lay Regulatory Groundwork For COVID-19 Vaccine
NPR, October 22, 2020. Dr. Diana Zuckerman spoke about making sure vaccines aren’t rushed through too quickly to be safe at the FDA advisory meeting on Covid-19 vaccine approval.
Read More »Study finds removing breast implants improved symptoms
AzFamily.com, October 1, 2020. The FDA is finally encouraging better information about the risks of cancer, breast implant illness, and other health problems for women considering breast implants. But we agree with patients that the agency could do so much more.
Read More »FDA Updates Breast Implant Labeling Recommendations to Help Inform Patients About Dangerous Potential Side Effects
Cure, September 29, 2020. Makers of breast implants should include a black box warning about cancer and other serious risks, along with a patient decision checklist for patients to sign, according to final guidance issued by the FDA.
Read More »How the Coronavirus Pandemic May Affect Cancer Clinical Trials
Cancer Therapy Advisor, August 18, 2020. The dangers of Covid-19, especially to cancer patients, are upending access to clinical trials for cancer treatments.
Read More »